Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro is available on the NHS in England, but the price depends entirely on how you access it. For most people right now, it is not available free at their GP — NHS eligibility criteria are strict and being rolled out in phases, meaning private treatment is the realistic route for many adults. Private Mounjaro prices in the UK have changed significantly since Eli Lilly raised its list price in September 2025, with typical private costs now ranging roughly £149 to £375 per month depending on dose and provider, as widely reported. These are prescription-only medicines: a prescriber assesses your suitability before any supply, whether through the NHS or a private pharmacy like ours.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
NICE recommended tirzepatide (Mounjaro) for NHS use in England in December 2024 (guidance updated in September 2025 under NICE technology appraisal TA1026) but eligibility is deliberately narrow and being introduced in stages. From June 2025, access opened to adults with a BMI of 40 or above who also have four or more specific weight-related conditions (high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, or type 2 diabetes). From around June 2026, that expanded to include adults with a BMI of 35 to 39.9 meeting the same condition count. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. Even when you meet the criteria, NHS supply depends on your practice participating in the new GP contract arrangements, which is optional, so access varies by area. Mounjaro on the NHS comes at standard prescription charge rates (currently around £9.90 per item in England, or free if you hold a prepayment certificate or qualify for exemption). The catch, for most people enquiring today, is simply that they do not yet qualify under the phased rollout. A detailed breakdown of NHS eligibility and what it costs through that route may answer your specific situation.
In the private market, the pen price you see advertised is not always the full story. Eli Lilly's UK list price increase in September 2025 pushed the highest-dose pen's list price from around £122 to around £330. Private providers pass on varying proportions of that increase, which is why reported typical monthly prices now range from roughly £149 at the lowest available dose to around £375 at the top. Those headline figures sometimes exclude a consultation fee, a separate prescription charge, delivery costs, or ongoing clinical support between doses. A prescription medicine assessed by a prescriber once and then left to you without aftercare is a different product from one with regular clinical check-ins. Worth checking what you are actually buying. The full guide to Mounjaro private pricing sets out the market context in more detail, including what the September 2025 price rise changed and what it means in practice for someone starting now versus someone already on a maintenance dose.
Price comparison makes sense for most purchases. For a prescription medicine available in counterfeit form (the MHRA has warned publicly about fake tirzepatide pens and reported seizures of illegally traded weight-loss medicines) it is the wrong starting point. The relevant questions are: is the pharmacy registered with the GPhC? Is a real clinician reviewing your notes before supply? Is the product sourced through the licensed UK supply chain? You can verify any online pharmacy on the GPhC register; our registration number is 9012878. If you want to understand whether Mounjaro is going up in price on the UK NHS, that context is worth reading before you decide between private and NHS routes. Sellers offering Mounjaro at prices well below the market range, or advertising codes and discounts, are red flags rather than bargains. An unusually low price on a prescription-only medicine often signals supply outside the regulated chain. If something feels off, report it through the Yellow Card scheme.
One transparent price at nume covers the consultation, the prescription, the medicine itself and free next-working-day DPD delivery. No hidden fees, no subscription, no auto-renewal. Every repeat order is clinically reviewed from scratch by a GPhC-registered Independent Prescriber before dispatch. A real clinician reads your answers the same day. We are not the cheapest private option; that is a deliberate choice. Running a GPhC-registered pharmacy with same-day clinical review, live weight verification by video, photo-ID checks and 7-day aftercare costs more than a largely automated system does, though if you are researching which chemist offers the cheapest Mounjaro we have put together a guide covering what those lower prices typically do and do not include. Current treatment pricing is shown on our treatment page, and the consultation to get there is free. If you are thinking about weight-loss treatment options more broadly, that page also covers how Mounjaro compares to the other licensed medicines we prescribe. Our clinical team is happy to answer questions about suitability before you commit to anything, and if you are waiting on the NHS Mounjaro deal to become available in your area, they can advise on your options in the meantime.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.